News

Nipro Diagnostics, Inc. Wins Manufacturer Of The Year Award From Manufacturers Association Of Florida

Diabetes Monitoring And Management Company Also Purchases Two Buildings In Fort Lauderdale, FL

November Is American Diabetes Month

November is American Diabetes Month, a time to rally individuals, communities, and families to Join the Millions in the movement to Stop Diabetes®. This year, the American Diabetes Association is asking individuals to take a pledge and raise their hand to Stop Diabetes.

AALTCN Launches Practical Learning Community

The American Association for Long Term Care Nursing (AALTCN) launched an interactive Learning Community this month. Listed in the "Education" section of the AALTCN website, is a valuable resource on a variety of topics relevant to long-term caregivers.

Educational Outreach Initiated by the WOCNCB

New video “Raising the Standard of Diabetic Wound Care” distributed internationally

National Alliance of Wound Care® Bestows First Advanced Credential in the Specialty of Diabetic Wounds

dwc.66.logo_.fnl_.color_clear.gif

  • Every 30 seconds a leg is lost to diabetes somewhere in the world
  • 85% of all diabetes-related amputations are preceded by foot ulcers
  • Research shows that up to 85% of all amputations can be prevented

District Court invalidates KCI patents and renders judgment in favor of Smith & Nephew, Full range of Smith & Nephew NPWT products continues to be available in U.S.

St. Petersburg, FL – October 18, 2010 – The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (LSE: SN; NYSE: SNN) today announced that the U.S. District Court for the Western District of Texas entered a favorable judgment in the patent litigation brought by Kinetic Concepts Inc. (NYSE: KCI) relating to the Smith & Nephew RENASYS™-F (Foam) dressing kit.

Calibra Gains FDA Clearance to Market Finesse(TM) Insulin Patch-Pen for Three-Day Use With Novolog(r)

Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse(TM) insulin patch-pen for up to three-day use with Novo Nordisk's Novolog(r) rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a small, adhesively attached, flat device that can be operated discretely through clothing to deliver mealtime, snack time, and correction bolus insulin in seconds.

O'Reilly Collins: Improper Insulin Monitoring Can Lead to Fatal Accidents

One of the worst case scenarios that can happen to a diabetic is if he or she falls into a hypoglycemic coma. This is caused by a severe deficiency in glucose levels found in the blood which causes the brain to seek other energy sources at the same time shutting down other important body functions. If treatment is delayed or neglected by the diabetic person, such a coma can cause not only loss of consciousness but also irreversible brain damage and death.

The Joe Toucan Diabetes Project Unveils the Joe Toucan Doll at AADE Conference

The Joe Toucan Diabetes Project, a 501(c)(3) organization focused
on researching, producing, and developing empowering projects,
supplies and accessories for children and young adults living with
diabetes, is happy to announce that it will publicly unveil its first product,
the Joe Toucan doll, at the American Association of Diabetes Educators
conference in San Antonio, Texas August 4-7, 2010. The American
Diabetes Association has acted in an advisory role for development of
the doll which was introduced at the American Diabetes Association's
Father of the Year awards in Los Angeles in June 2010. The Joe Toucan
Diabetes Project's CEO Lawrence Goldfarb was given this year's award
and Joe Toucan President Rocky Lang was awarded in 2009, both for
their work on the Joe Toucan doll.

Protein Important in Diabetes May Also Play Key Role in Heart Disease

Studying a protein already known to play an important role in type 2 diabetes and cancer, genomics researchers have discovered that it may have an even broader role in disease, particularly in other metabolic disorders and heart disease. In finding unsuspected links to other disease-related genes, the scientists may have identified future targets for drug treatments.

Recent comments